Paeonol induces apoptosis in human ovarian cancer cells

Acta Histochemica

Volumn 115, Issue 8, 2013, Pages 835-839

  Yin, Juan ^a   Wu, Nanshun ^a   Zeng, Fanqing ^a   Cheng, Chao ^b   Kang, Kai ^a   Yang, Huan ^a  

^a Ninth People's Hospital of Chongqing   (China)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Caspase 3; Ovarian cancer; Paeonol; Survivin

Indexed keywords

CASPASE 3; PEONOL; SURVIVIN; ACETOPHENONE DERIVATIVE; ANTINEOPLASTIC AGENT;

APOPTOSIS; ARTICLE; CANCER CELL; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN CELL; OVARY CANCER; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; FEMALE; OVARIAN NEOPLASMS; PATHOLOGY; STRUCTURE ACTIVITY RELATION; TUMOR CELL CULTURE;

ACETOPHENONES; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; OVARIAN NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 84887145104     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2013.04.004     Document Type: Article

References (34)

1. Aune G., Stunes A.K., Tingulstad S., Salvesen O., Syversen U., Torp S.H. The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas. Int J Clin Exp Pathol 2011, 4:444-453.
2. Azrak R.G., Frank C.L., Ghadersohi A., Rustum Y.M. Silencing survivin results in synergy between methylseleninic acid and paclitaxel against skov3 ovarian cancer cells. Cancer Biol Ther 2008, 7:1901-1908.
3. Chen J., Wang M., Xi B., Xue J., He D., Zhang J., et al. SPARC is a key regulator of proliferation, apoptosis and invasion in human ovarian cancer. PLoS One 2012, 7:e42413.
4. Chen Q., Liu S.Q., Du Y.M., Peng H., Sun L.P. Carboxymethyl-chitosan protects rabbit chondrocytes from interleukin-1 beta-induced apoptosis. Eur J Pharmacol 2006, 541:1-8.
5. Chunhu Z., Suiyu H., Meiqun C., Guilin X., Yunhui L. Antiproliferative and apoptotic effects of paeonol on human hepatocellular carcinoma cells. Anticancer Drugs 2008, 19:401-409.
6. Di Giorgio A., Naticchioni E., Biacchi D., Sibio S., Accarpio F., Rocco M., et al. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. Cancer 2008, 113:315-325.
7. Han C.H., Wei Q., Lu K.K., Liu Z., Mills G.B., Wang L.E. Polymorphisms in the survivin promoter are associated with age of onset of ovarian cancer. Int J Clin Exp Med 2009, 2:289-299.
8. Hilliard T.S., Gaisina I.N., Muehlbauer A.G., Gaisin A.M., Gallier F., Burdette J.E. Glycogen synthase kinase 3β inhibitors induce apoptosis in ovarian cancer cells and inhibit in-vivo tumor growth. Anticancer Drugs 2011, 22:978-985.
9. Huang H., Chang E.J., Lee Y., Kim J.S., Kang S.S., Kim H.H. A genome-wide microarray analysis reveals anti-inflammatory target genes of paeonol in macrophages. Inflamm Res 2008, 57:189-198.
10. Kim S.H., Kim S.A., Park M.K., Kim S.H., Park Y.D., Na H.J., et al. Paeonol inhibits anaphylactic reaction by regulating histamine and TNF-alpha. Int Immunopharmacol 2004, 4:279-287.
11. Larsen B.D., Megeney L.A. Parole terms for a killer: directing Caspase 3/CAD induced DNA strand breaks to coordinate changes in gene expression. Cell Cycle 2010, 9:2940-2945.
12. Larsen B.D., Rampalli S., Burns L.E., Brunette S., Dilworth F.J., Megeney L.A. Caspase 3/caspase-activated DNase promote cell differentiation by inducing DNA strand breaks. Proc Natl Acad Sci U S A 2010, 107:4230-4235.
13. Lau C.H., Chan C.M., Chan Y.W., Lau K.M., Lau T.W., Lam F.C., et al. Pharmacological investigations of the anti-diabetic effect of Cortex Moutan and its active component paeonol. Phytomedicine 2007, 14:778-784.
14. Lee H.J., Kim S.A., Lee H.J., Jeong S.J., Han I., Jung J.H., et al. Paeonol oxime inhibits bFGF-induced angiogenesis and reduces VEGF levels in fibrosarcoma cells. PLoS One 2010, 5:e12358.
15. Liguang Z., Peishu L., Hongluan M., Hong J., Rong W., Wachtel M.S., et al. Survivin expression in ovarian cancer. Exp Oncol 2007, 29:121-125.
16. Meng J.R., Tang H.Z., Zhou K.Z., Shen W.H., Guo H.Y. TFF3 and survivin expressions associate with a lower survival rate in gastric cancer. Clin Exp Med 2012, DOI 10.1007/s10238-012-0210-9.
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
18. MM A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
19. Nizamutdinova I.T., Oh H.M., Min Y.N., Park S.H., Lee M.J., et al. Paeonol suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells by blocking p38, ERK and nuclear factor-kappaB signaling pathways. Int Immunopharmacol 2007, 7:343-350.
20. Pizem J., Cör A., Zadravec Zaletel L., Popovic M. Prognostic significance of apoptosis in medulloblastoma. Neurosci Lett 2005, 381:69-73.
21. Sun G.P., Wan X., Xu S.P., Wang H., Liu S.H., Wang Z.G. Antiproliferation and apoptosis induction of paeonol in human esophageal cancer cell lines. Dis Esophagus 2008, 21:723-729.
22. Takasu C., Shimada M., Kurita N., Iwata T., Sato H., Nishioka M., et al. Survivin expression can predict the effect of chemoradiotherapy for advanced lower rectal cancer. Int J Clin Oncol 2012, DOI 10.1007/s10147-012-0470-0.
23. Tentes A.A., Korakianitis O.S., Kakolyris S., Kyziridis D., Veliovits D., Karagiozoglou C., et al. Cytoreductive surgery and periopeartive intraperitoneal chemotherapy in recurrent ovarian cancer. Tumori 2010, 96:411-416.
24. Tsai H.Y., Lin H.Y., Fong Y.C., Wu J.B., Chen Y.F., et al. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway. Eur J Pharmacol 2008, 588:124-133.
25. Vasey P.A. Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies. Br J Cancer 2003, 89:S23-S28.
26. Vivas-Mejia P.E., Rodriguez-Aguayo C., Han H.D., Shahzad M.M., Valiyeva F., Shibayama M., et al. Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancer. Clin Cancer Res 2011, 17:3716-3726.
27. Vucic D., Franklin M.C., Wallweber H.J., Das K., Eckelman B.P., Shin H., et al. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP. Biochem J 2005, 385:11-20.
28. Wan X.A., Sun G.P., Wang H., Xu S.P., Wang Z.G., Liu S.H. Synergistic effect of paeonol and cisplatin on oesophageal cancer cell lines. Dig Liver Dis 2008, 40:531-539.
29. Wang Y.Q., Dai M., Zhong J.C., Yin D.K. Paeonol inhibits oxidized low density lipoprotein-induced monocyte adhesion to vascular endothelial cells by inhibiting the mitogen activated protein kinase pathway. Biol Pharm Bull 2012, 35:767-772.
30. Weng D., Song X., Xing H., Ma X., Xia X., Weng Y., et al. Implication of the Akt2/survivin pathway as a critical target in paclitaxel treatment in human ovarian cancer cells. Cancer Lett 2009, 273:257-265.
31. Xing G., Zhang Z., Liu J., Hu H., Sugiura N. Antitumor effect of extracts from moutan cortex on DLD-1 human colon cancer cells in vitro. Mol Med Report 2010, 3:57-61.
32. Xu C., Yamamoto-Ibusuki M., Yamamoto Y., Yamamoto S., Fujiwara S., Murakami K., et al. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level. Breast Cancer 2012, DOI 10.1007/s12282-012-0403-9.
33. Yin J., Yu C., Yang Z., He J.L., Chen W.J., Liu H.Z., et al. Tetramethylpyrazine inhibits migration of SKOV3 human ovarian carcinoma cells and decreases the expression of interleukin-8 via the ERK1/2, p38 and AP-1 signaling pathways. Oncol Rep 2011, 26:671-679.
34. Zhong S.Z., Ge Q.H., Qu R., Li Q., Ma S.P. Paeonol attenuates neurotoxicity and ameliorates cognitive impairment induced by d-galactose in ICR mice. J Neurol Sci 2009, 277:58-64.